Archive: CIPO2015: Durable Immune Control of ALL Requires a Multi-Antigen Immune Response
97 views · Published 15 October 2015 · 15:02 · Indexed 20 October 2026
Channel: UW Video · 2015 · Education
Dr. Alix Seif of The Children’s Hospital of Philadelphia speaks at the 4th International Conference on Immunotherapy in Pediatric Oncology (CIPO2015), hosted by Seattle Children’s Research Institute. Dr. Seif discusses the effectiveness of current single antigen-targeted immunotherapies for acute lymphoblastic leukemia (ALL) and how tolerance to tumor antigens preventing an immune response to neoantigen-bearing ALL can be partially overcome by the addition of an innate immune stimulant. Alix Seif, MD, MPH, Assistant Professor, The Children’s Hospital of Philadelphia 09/26/2015 http://www.seattlechildrens.org/research/ http://www.seattlechildrens.org/research/childhood-cancer/CIPO-2015/ https://uw.edu/video The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.
More from this channel
-
54:45
Archive: Usable Privacy and Security: Protecting People from Online Phishing Scams
-
58:27
Archive: Technology for Long-Term Care: Scaling Elder Care to the Next Billion
-
53:34
Archive: Closing the Innovation Gap
-
52:34
Archive: Hardness Amplification by Repetition
-
54:57
Archive: Network Coded Wireless Architecture
-
56:48
Archive: Computer Science Research for Global Development
-
58:16
Archive: Thinking Historically about Thinking Historically: Identity Politics to Ethical Action
-
27:18
Archive: Eastside Specialty Center: Coordination of Care